SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-12-006380
Filing Date
2012-12-14
Accepted
2012-12-14 16:05:54
Documents
3
Period of Report
2012-12-14
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 8-K a50508650.htm 8-K 22980
2 EXHIBIT 3.1 a50508650ex3_1.htm EX-3.1 7159
3 EXHIBIT 99.1 a50508650ex99_1.htm EX-99.1 9886
  Complete submission text file 0001157523-12-006380.txt   41577
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 121265655
SIC: 2834 Pharmaceutical Preparations